ArticleCancers2022

Establishment of Novel Neuroendocrine Carcinoma Patient-Derived Xenograft Models for Receptor Peptide-Targeted Therapy.

Catherine G Tran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.